Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -750.37 Thousand | -2.25 Million | -4.12 Million | -1.41 Million | -2.33 Million | -1.28 Million |
| Net Income | -13.2 Million | -3.06 Million | -5.87 Million | -5.51 Million | -6.53 Million | -3.88 Million |
| Depreciation & Amortization | 26.21 Thousand | 21.02 Thousand | 1.28 Million | 1.29 Million | 778.23 Thousand | - |
| Deferred income taxes | -1.01 Million | -190 Thousand | -833.54 Thousand | -2.79 Million | -442.74 Thousand | - |
| Stock-based compensation | 1.74 Million | 344.75 Thousand | 599.76 Thousand | 774.81 Thousand | 527.66 Thousand | 90.07 Thousand |
| Change in working capital | 294.03 Thousand | 687.21 Thousand | -131.57 Thousand | -252.04 Thousand | 394.92 Thousand | -476.34 Thousand |
| Other non-cash items | 11.82 Million | -56.07 Thousand | 830.56 Thousand | 5.08 Million | 2.94 Million | 2.98 Million |
| Investing Cash Flow | 995.04 Thousand | 77.57 Thousand | 1.48 Million | 3.78 Million | -7.31 Million | -774.1 Thousand |
| Investments in PPE | 2.00 | - | -42.71 Thousand | -17.96 Thousand | -19.04 Thousand | - |
| Acquisitions | 741.54 Thousand | -12.16 Thousand | 309.1 Thousand | 2.17 Million | -7.08 Million | -403.42 Thousand |
| Investment purchases | - | - | 42.71 Thousand | -492.07 Thousand | -230.13 Thousand | -370.67 Thousand |
| Sales/Maturities of investments | 253.49 Thousand | 94.07 Thousand | 1.21 Million | 2.11 Million | 230.13 Thousand | - |
| Other Investing Activities | 995.04 | -4336.00 | -42.71 Thousand | 3.79 Million | -214.82 Thousand | -774.1 Thousand |
| Financing Cash Flow | 304 Thousand | 843.24 Thousand | 776.97 Thousand | 132.23 Thousand | 9.5 Million | 1.77 Million |
| Debt repayment | -4000.00 | -48.19 Thousand | -64.02 Thousand | -2.19 Million | -20.29 Thousand | -400 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 300 Thousand | 280 Thousand | 953.96 Thousand | 200 Thousand | 1.72 Million | 952.72 Thousand |
| Other Financing Activities | 300 Thousand | 611.44 Thousand | 841 Thousand | 2.12 Million | 7.8 Million | 820.55 Thousand |
| Accounts receivables | 3775.00 | -56.67 Thousand | 60.4 Thousand | -250.26 Thousand | -176.35 Thousand | 7765.00 |
| Accounts payables | 351.58 Thousand | 571.31 Thousand | -122.71 Thousand | -88.41 Thousand | 591.38 Thousand | - |
| Inventory | - | 73.4 Thousand | -116.15 Thousand | 77.28 Thousand | -95.15 Thousand | - |
| Other working capital | -61.32 Thousand | 99.16 Thousand | 46.89 Thousand | 9346.00 | 75.04 Thousand | -484.11 Thousand |
| Cash at beginning of period | 8555.00 | 957.98 Thousand | 2.13 Million | 73.67 Thousand | 155.11 Thousand | 499.47 Thousand |
| Cash at end of period | 560.12 Thousand | 8555.00 | 957.98 Thousand | 2.13 Million | 73.67 Thousand | 155.11 Thousand |
| Capital Expenditure | 2.00 | - | -42.71 Thousand | -17.96 Thousand | -19.04 Thousand | - |
| Effect of forex changes on cash | 3052.00 | 386.9 Thousand | 690.62 Thousand | -438.55 Thousand | 67.31 Thousand | -56.25 Thousand |
| Net cash flow / Change in cash | 551.57 Thousand | -949.42 Thousand | -1.17 Million | 2.06 Million | -81.44 Thousand | -344.35 Thousand |
| Free Cash Flow | -750.37 Thousand | -2.25 Million | -4.16 Million | -1.43 Million | -2.35 Million | -1.28 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -131.08 Thousand | -496.99 Thousand | -12.3 Million | -13.2 Million | -300 Thousand | -419.97 Thousand |
| Depreciation & Amortization | 12.56 Thousand | 12.56 Thousand | 26.21 Thousand | 26.21 Thousand | - | - |
| Deferred income taxes | - | - | - | -1.01 Million | - | - |
| Stock-based compensation | 47.23 Thousand | - | 1.74 Million | 1.74 Million | - | - |
| Change in working capital | -202.7 Thousand | -107.62 Thousand | -57.55 | 294.03 Thousand | - | 131.18 Thousand |
| Other non-cash items | 136.73 Thousand | 120.09 Thousand | 11.95 Million | 11.82 Million | 141.14 Thousand | 158.76 Thousand |
| Investing Cash Flow | - | - | 741.24 Thousand | 995.04 Thousand | 8042.00 | 37.83 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 741.54 Thousand | 741.54 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | -300.00 | 253.49 Thousand | 8042.00 | 37.83 Thousand |
| Other Investing Activities | - | - | 741.24 | 995.04 | 8.04 | 37.83 Thousand |
| Financing Cash Flow | - | 326 Thousand | 27.38 Thousand | 304 Thousand | 300 Thousand | 93.15 Thousand |
| Debt repayment | - | - | -4000.00 | -4000.00 | -23.38 Thousand | -23.38 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 326 Thousand | 300 Thousand | 300 Thousand | - | - |
| Other Financing Activities | - | 326.00 | 225.51 | 300 Thousand | - | 116.54 Thousand |
| Accounts receivables | 4842.00 | -46.66 Thousand | 3.78 | 3775.00 | - | -3862.00 |
| Accounts payables | -157.54 Thousand | - | - | 351.58 Thousand | - | 130.48 Thousand |
| Inventory | - | - | - | - | - | 3862.00 |
| Other working capital | -207.54 Thousand | -60.96 Thousand | -61.32 | -61.32 Thousand | - | 697.00 |
| Cash at beginning of period | 342.37 Thousand | 560.12 Thousand | 160.09 Thousand | 8555.00 | 9923.00 | 8361.00 |
| Cash at end of period | 137.6 Thousand | 342.37 Thousand | 560.12 Thousand | 560.12 Thousand | 160.09 Thousand | 9923.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 773.00 | 3052.00 | 993.00 | 600.00 |
| Net cash flow / Change in cash | -204.77 Thousand | -217.75 Thousand | 400.03 Thousand | 551.57 Thousand | 150.17 Thousand | 1562.00 |
| Free Cash Flow | -204.77 Thousand | -543.75 Thousand | -369.22 Thousand | -750.37 Thousand | -158.86 Thousand | -130.02 Thousand |
0HF9
0369
KANSHST
6648
003380
HAKI-B